BioSpace News Archive

Business

AstraZeneca Q1: “Something Tangible to Believe In”

AstraZeneca reported first-quarter financials, with Product Sales growing 10% (14% at CER) to $5.465 billion. What is more startling, and completely in accordance with the company’s stated goals, Global Oncology sales increased by 54%.

April 26, 2019
·
3 min read
·
Mark Terry
Business

Expedeon Reports Financial Results for Fiscal Year 2018 – Financial Guidance Met

Conference call to be held today, 25 April 2019, 3:00pm CET/2:00pm BST

April 26, 2019
·
8 min read
Business

Björn Carlsson, CEO of Monocl, accepted into Forbes Young Entrepreneur Council

Young Entrepreneur Council is an invitation-only community for the world’s most successful entrepreneurs.

April 26, 2019
·
2 min read
Policy

/R E P E A T -- Notice to the media - Chief Public Health Officer to chair discussion on the spread of misinformation about vaccines on social media/

Dr. Theresa Tam, Canada’s Chief Public Health Officer, will convene a panel discussion, hosted by the Public Policy Forum, on the spread of misinformation about vaccines on social media and the impact it is having on vaccine-preventable diseases in Canada.

April 26, 2019
·
1 min read
Business

Hill-Rom Reports Fiscal Second Quarter Financial Results

New Product Momentum, Solid Execution Drives Revenue Growth and Margin Expansion

April 26, 2019
·
10 min read
Drug Development

ReNeuron Announces Presentation of Updated Efficacy and Safety Data from Retinitis Pigmentosa Study at the Sixth Annual Retinal Cell and Gene Therapy Innovation Summit

hRPC Cell Therapy Demonstrates Sustained and Further Improvement in Vision at 60 and 120 Days in First Cohort of Phase 2a study in Retinitis Pigmentosa

April 26, 2019
·
5 min read
Deals

BioPharmX Completes 1-for-25 Reverse Stock Split

BioPharmX Corporation announces the completion of the reverse stock split previously announced on April 15, 2019 to regain compliance with certain NYSE American continued listing standards related to the low price per share of the Company’s common stock.

April 26, 2019
·
2 min read
BioMidwest

Navidea Biopharmaceuticals Announces Comparative Study to Evaluate the Potential Utility of Tilmanocept In Patients with Tuberculosis (“TB”)

New comparative study of 68Ga-Tilmanocept and 18F-FDG PET/CT in the evaluation of patients with TB

April 26, 2019
·
7 min read
Biotech Bay

BioTime to Present SCiStar Clinical Study Top-Line Data at the 26th Annual American Society for Neural Therapy and Repair Conference

BioTime, Inc. announced that Edward D. Wirth, III, M.D., Ph.D., Chief Medical Officer of BioTime, will present at the 26th Annual American Society for Neural Therapy and Repair (ASNTR) Annual Conference on April 26th, 2019 at 10:30am EDT as part of Session 6: “Spinal Cord Injury”.

April 26, 2019
·
10 min read
Genetown

LifePod wins Best of Show in Patient-Focused Software at the Bio-IT World Conference & Expo

LifePod Solutions, the first proactive-voice caregiving service, has announced that it has won a Best of Show award in Patient-Focused Software at the 2019 Bio-IT World Conference & Expo.

April 26, 2019
·
4 min read